Barclays raised the firm’s price target on Marex Group (MRX) to $50 from $49 and keeps an Overweight rating on the shares post the Q4 report. The company’s Q4 results were solid, but its commentary that the high-volatility environment was less than optimal weighed on shares, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRX:
- Crypto Currents: Core Scientific sells BTC for AI amid Iran unrest
- Marex Group Posts Record Q4 and Full-Year 2025 Results on Broad-Based Growth
- Marex Group reports Q4 adjusted EPS $1.13, consensus $1.02
- Marex Group has agreed to acquire Webb Traders
- Marex Group price target raised to $61 from $54 at TD Cowen